Prognostic significance of maximum tumour (bulk) diameter in young patients with good-prognosis diffuse large-B-cell lymphoma treated with CHOP-like chemotherapy with or without rituximab: an exploratory analysis of the MabThera International Trial Group (MInT) study

Publication | Closed Access

DOI

221

Citations

References

2008

Year

Michael Pfreundschuh, Anthony D. Ho, Eva Cavallin‐Ståhl, Max Wolf, Ruth Pettengell, Ingrid Vášová, Andrew R. Belch, Jan Walewski, Pier Luigi Zinzani, Walter Mingrone,

The Lancet Oncology

Hematological MalignancyLymphoid NeoplasiaMaximum TumourMedicineMalignant Blood DisorderImmunologyPathologyChop-like ChemotherapyPrognostic SignificanceImmunotherapyOncologyCancer Research